期刊文献+

2型神经纤维瘤病临床特征分析 被引量:5

Analysis of clinical characteristics of neurofibromatosis 2
原文传递
导出
摘要 目的探讨2型神经纤维瘤病(NF2)的临床特征。方法回顾性分析69例NF2的临床特征。结果本组15例有家族史,平均发病年龄为27.3岁,发病年龄无性别差异,67例(97%)有听神经瘤,37例(54%)伴发脑膜瘤,31例(45%)伴发椎管肿瘤,33例(48%)以听神经瘤症状起病,13例(19%)以椎管病变起病。57例病人在我院行78次手术,1例死亡(死亡率1.4%)。随访到40例,KPS60分以上21例,7例病人死亡。结论NF2往往累及全身多个系统,需要由多学科协作进行个性化治疗。 Objective To study the clinical characteristics of Neurofibromatosis 2. Methods We evaluated 69 affected patients from Jan 2001 to Aug 2008 in the department of neurosurgery in Beijing Tiantan Hospital. Results The mean age at onset in 69 cases was 27. 3. There was no statistical difference between male and female. The vestibular schwannoma was documented in 97% individuals. The other findings included meningiomas (54%) and spinal tumors (45%). The initial symptoms resulted from Vestibular schwannomas(48% ) and spinal tumors( 19% ). 78 operations were performed for 57 cases. The mortality was 1.4%. 40 cases were followed, and the KPS of 21 patients were above 60. 7 cases died. Conclusions Patients with NF2 always have diseases involved multiple systems, and individualized treatment strategy needs the cooperation of muhidisciplinary.
出处 《中华神经外科杂志》 CSCD 北大核心 2009年第4期330-332,共3页 Chinese Journal of Neurosurgery
基金 首都医学发展科研基金(2007-2064).
关键词 2型神经纤维瘤病 临床特征 听神经瘤 Neurofibromatosis 2 Clinical characteristics Vestibular schwannoma
  • 相关文献

参考文献12

  • 1Ferner RE. Neurofi bromatosis 1 and neurofibromatosis 2 : a twenty first century perspective. Lancet Neurol, 2007, 6 : 340-351.
  • 2卞留贯,孙青芳,沈建康,罗其中.多发神经纤维瘤病的临床和分子生物学研究[J].中华神经外科疾病研究杂志,2005,4(5):477-479. 被引量:10
  • 3Baser ME, Friedman JM, Wallace A J, et al. Evaluation of clinical diagnostic criteria for neurofibromatosis 2. Neurology, 2002, 59 : 1759-1765.
  • 4Parry DM, Eldridge R, Kaiser-Kupfer MI, et al. Neurofibromatosis 2 ( NF2 ) : clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet, 1994, 52 : 450- 461.
  • 5罗世祺,石祥恩.双侧听神经瘤[J].中华神经外科杂志,1995,11(5):267-269. 被引量:10
  • 6Evans DG, Huson SM, Donnai D, et al. A clinical study of type 2 neurofibromatosis. Q J Med, 1992, 84: 603-618.
  • 7Sener RN, Dzelzite S, Migals A, et al. Prominent myelin vacuolization in neurofibromatosis type 2. Clin Imaging, 2003, 27 : 11-13.
  • 8Samii M, Gerganov V,Samii A. Microsurgery management of vestibular schwannomas in neurofibromatosis type 2: indications and results. Prog Neurnl Surg, 2008,21:169-175.
  • 9Matsuno A, Nagashima T. Radiosurgery in NF2. J Neurosurg, 1999,91:714-715.
  • 10廖慧娟,廖二元,蒋波,魏启幼.2型神经纤维瘤病NF2基因的突变分析[J].中国临床医学,2005,12(4):585-587. 被引量:2

二级参考文献12

  • 1陈炳桓,中华神经外科杂志,1985年,1卷,209页
  • 2Arai E, Ikeuchi T, Karasawa S, et al. Constitutional translocation t(4;22) (q12;q12. 2) associated with neurofibromatosis type 2[J]. Am J Med Genet, 1992, 44 :163-167.
  • 3Rouleau GA, Merel P, Lutchman M, et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2[J]. Nature, 1993, 363:515-521.
  • 4Trofatter JA, MacCollin MM, Rutter JL, et al. A novel moesin-,ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor[J]. Cell, 1993, 72:791-800.
  • 5MacCollin M, Mohney T, Trofatter J, et al. DNA diagnosis of neurofibrornatosis 2. Altered coding sequence of the merlin tumor suppressor in an extended pedigree[J]. JAMA, 1993, 270:2316-2320.
  • 6Wellenreuther R, Kraus JA, Lenartz D, et al. Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma[J]. Am J Pathol, 1995, 146:827-832.
  • 7Rubio MP, Correa KM, Ramesh V, et al. Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas[J]. Cancer Res, 1994, 54:45-47.
  • 8卞留贯.NF2肿瘤抑制基因与中枢神经系统良性肿瘤[J].国外医学(神经病学.神经外科学分册),1998,25(3):124-127. 被引量:15
  • 9卞留贯,沈建康,罗其中.散发神经鞘瘤22号染色体杂合子丢失[J].中国神经精神疾病杂志,2000,26(4):225-227. 被引量:7
  • 10王晓斌,刘国仰.有关内含子功能研究的新进展[J].中华医学遗传学杂志,2000,17(3):211-212. 被引量:33

共引文献19

同被引文献56

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部